The manufacturing licence of Noida-based Marion Biotech Pvt Ltd was cancelled by the Uttar Pradesh Ministry of Food and Drug Safety in the aftermath of the deaths of 18 children in Uzbekistan, last year. Reports alleged that they died after consuming cough syrup manufactured by the firm.&nbsp;

A senior state health official said on Wednesday, "Marion Biotech Company's licence has been cancelled by the State License Authority." The Central Drugs Standard Control Organisation and the State health regulator decided to cancel the licence unanimously.&nbsp;

The government official said that the firm's licence was under suspension since January after which a "detailed inquiry was initiated". The official added that the firm can no longer "manufacture the syrup".

The official noted that the Noida Police arrested three employees of Marion Biotech from its Noida office on March 3. A lookout notice was issued for two of its directors after an FIR was lodged against all of them.&nbsp;

The FIR had come after an initial probe found that samples of Marion Biotech were "adulterated" and "not of standard quality."&nbsp;

Last year, Uzbekistan's health ministry earlier claimed in a statement that the children died after consuming cough syrup Doc-1 Max, manufactured by Marion Biotech—an Indian drugmaker. Concerns were raised when Uzbek's health ministry said that the syrup contained a toxic substance known as ethylene glycol.&nbsp;

The World Health Organization (WHO) in January had also issued a 'medical product alert' regarding products identified in Uzbekistan and reported to it on December 22, 2022.&nbsp;

"The two products are Ambronol syrup and DOK-1 Max syrup. The stated manufacturer of both products is MARION BIOTECH PVT LTD, (Uttar Pradesh, India). To date, the stated manufacturer has not provided guarantees to WHO on the safety and quality of these products," the WHO had stated then.&nbsp;

"Laboratory analysis of samples of both products, undertaken by national quality control laboratories of the Ministry of Health of the Republic of Uzbekistan found both products contained unacceptable amounts of diethylene glycol and/or ethylene glycol as contaminants," it had noted.&nbsp;

WATCH WION LIVE HERE

<iframe allow="accelerometer; autoplay; encrypted-media; gyroscope; picture-in-picture" allowfullscreen="" frameborder="0" height="350" loading="”lazy”" src="https://www.wionews.com/live-tv/embed?autoplay=1&amp;mute=1" width="100%"></iframe>

You can now write for wionews.com and be a part of the community. Share your stories and opinions with us <a href="https://www.wionews.com/content-contribution-registration-form">here</a>.

The manufacturing licence of Noida-based Marion Biotech Pvt Ltd was cancelled by the Uttar Pradesh Ministry of Food and Drug Safety in the aftermath of the deaths of 18 children in Uzbekistan, last year.

The manufacturing licence of Noida-based Marion Biotech Pvt Ltd was cancelled by the Uttar Pradesh Ministry of Food and Drug Safety in the aftermath of the deaths of 18 children in Uzbekistan, last year. Reports alleged that they died after consuming cough syrup manufactured by the firm. A senior state health official said on Wednesday, "Marion Biotech Company's licence has been cancelled by the State License Authority." The Central Drugs Standard Control Organisation and the State health regulator decided to cancel the licence unanimously. The government official said that the firm's licence was under suspension since January after which a "detailed inquiry was initiated". The official added that the firm can no longer "manufacture the syrup". The official noted that the Noida Police arrested three employees of Marion Biotech from its Noida office on March 3. A lookout notice was issued for two of its directors after an FIR was lodged against all of them. The FIR had come after an initial probe found that samples of Marion Biotech were "adulterated" and "not of standard quality." Last year, Uzbekistan's health ministry earlier claimed in a statement that the children died after consuming cough syrup Doc-1 Max, manufactured by Marion Biotech—an Indian drugmaker. Concerns were raised when Uzbek's health ministry said that the syrup contained a toxic substance known as ethylene glycol. The World Health Organization (WHO) in January had also issued a 'medical product alert' regarding products identified in Uzbekistan and reported to it on December 22, 2022. "The two products are Ambronol syrup and DOK-1 Max syrup. The stated manufacturer of both products is MARION BIOTECH PVT LTD, (Uttar Pradesh, India). To date, the stated manufacturer has not provided guarantees to WHO on the safety and quality of these products," the WHO had stated then. "Laboratory analysis of samples of both products, undertaken by national quality control laboratories of the Ministry of Health of the Republic of Uzbekistan found both products contained unacceptable amounts of diethylene glycol and/or ethylene glycol as contaminants," it had noted. WATCH WION LIVE HERE You can now write for wionews.com and be a part of the community. Share your stories and opinions with us here.

Marion Biotech's manufacturing licence cancelled over kids' deaths in Uzbekistan

India may issue a notice regarding cough syrup sold by Marion Biotech, whose medicines have been linked to the deaths of several children in&nbsp;Uzbekistan, as&nbsp;testing revealed that many of the company's medicine samples contained toxins, an Indian drug inspector stated on Saturday (March 4), as per an exclusive Reuters report.&nbsp;

After tests in a government laboratory that revealed 22 of 36 samples of the syrup to be "adulterated and spurious," Indian police detained three Marion workers on Friday (March 3) and are searching for the firm's two directors.

According to Vaibhav Babbar, an inspector working on the Marion probe, who spoke to Reuters, the samples were contaminated with ethylene glycol and diethylene glycol, which the World Health Organization claims were present in the items marketed by the two corporations in the two nations.

There have been 19 child deaths in Uzbekistan and up to 70 in the Gambia.

ALSO READ |&nbsp;<a href="https://www.wionews.com/india-news/from-april-india-jewellers-required-to-sell-hallmarked-gold-568542">From April 1, only gold jewellery with hallmarking to be sold in India</a>

As per&nbsp;data released by the World Health Organiazation (WHO) in January, acute renal damage brought on by adulterated medications claimed the lives of more than 300 children, most of whom were under the age of five, in Gambia, Indonesia, and Uzbekistan last year.

The Philippines, Timor Leste, Senegal, and Cambodia were all mentioned as possible impacted countries since they may have the drugs available for purchase. Moreover, it urged its 194 member nations to take "urgent and coordinated measures" to stop further fatalities.

ALSO WATCH |&nbsp;Antony Blinken takes auto-rickshaw ride during New Delhi visit

<div class="videoWrapper trancodeVideo"><iframe allowfullscreen="" autoplay="1" class="includeVideo" frameborder="0" height="350" src="https://www.wionews.com/videos/antony-blinken-takes-auto-rickshaw-ride-during-new-delhi-visit-568656/embed" style="width:100%;max-width:560px;" width="560"></iframe></div>

The WHO claimed that four of Maiden's cough syrups, another pharmaceuticals company in India&nbsp;may have killed dozens of children in Gambia, prompting India to halt production at Maiden for breaking manufacturing regulations in October, 2022.&nbsp;

Maiden has refuted claims that the deaths in the Gambia were caused by its medications, and testing conducted by an Indian government laboratory detected no contaminants in its samples.

(With inputs from agencies) 
&nbsp;

WATCH WION LIVE HERE:

<iframe allowfullscreen="" autoplay="1" class="includeVideo" frameborder="0" height="350" src="https://www.wionews.com/live-tv/embed" style="width:100%;max-width:560px;" width="560"></iframe>

India may issue a notice regarding cough syrup sold by Marion Biotech, whose medicines have been linked to the deaths of several children in Uzbekistan, as testing revealed that many of the company's medicine samples contained toxins, an Indian drug inspector stated on Saturday (March 4), as per an exclusive Reuters report.

India may issue a notice regarding cough syrup sold by Marion Biotech, whose medicines have been linked to the deaths of several children in Uzbekistan, as testing revealed that many of the company's medicine samples contained toxins, an Indian drug inspector stated on Saturday (March 4), as per an exclusive Reuters report. After tests in a government laboratory that revealed 22 of 36 samples of the syrup to be "adulterated and spurious," Indian police detained three Marion workers on Friday (March 3) and are searching for the firm's two directors. According to Vaibhav Babbar, an inspector working on the Marion probe, who spoke to Reuters, the samples were contaminated with ethylene glycol and diethylene glycol, which the World Health Organization claims were present in the items marketed by the two corporations in the two nations. There have been 19 child deaths in Uzbekistan and up to 70 in the Gambia. ALSO READ | From April 1, only gold jewellery with hallmarking to be sold in India As per data released by the World Health Organiazation (WHO) in January, acute renal damage brought on by adulterated medications claimed the lives of more than 300 children, most of whom were under the age of five, in Gambia, Indonesia, and Uzbekistan last year. The Philippines, Timor Leste, Senegal, and Cambodia were all mentioned as possible impacted countries since they may have the drugs available for purchase. Moreover, it urged its 194 member nations to take "urgent and coordinated measures" to stop further fatalities. ALSO WATCH | Antony Blinken takes auto-rickshaw ride during New Delhi visit The WHO claimed that four of Maiden's cough syrups, another pharmaceuticals company in India may have killed dozens of children in Gambia, prompting India to halt production at Maiden for breaking manufacturing regulations in October, 2022. Maiden has refuted claims that the deaths in the Gambia were caused by its medications, and testing conducted by an Indian government laboratory detected no contaminants in its samples. (With inputs from agencies) WATCH WION LIVE HERE:

India may issue alert on Marion cough syrup exports as lab tests find toxins

India suspended production at a pharmaceutical company after its cough syrup was linked to the death of 19 children in Uzbekistan. The cough syrup was manufactured by the Indian drug-maker Marion Biotech and has killed at least 19 children in Uzbekistan's Samarkand.

Uzbekistan: Cough syrup kills 19 children, country blames India-made syrups for deaths

India on Friday (December 30) suspended cough syrup maker's production after reports emerged that the medicine was linked to the deaths of 19 children in Uzbekistan. Indian Health Minister Mansukh Mandaviya said that all production had been suspended at Marion Biotech's unit in Noida, a city in the northern state of Uttar Pradesh.&nbsp;

Mandaviya wrote on Twitter on Friday: "All manufacturing activities of Marion Biotech at Noida unit have been stopped yesterday night, while further investigation is ongoing."&nbsp;

Hasan Harris, who is the legal head of Marion, told India-based news agency ANI that the company had halted production of all medicines. They are now waiting for the Indian government's report on the inspection.&nbsp;

Uzbekistan's health ministry earlier claimed in a statement that the children died after consuming cough syrup Doc-1 Max, manufactured by Marion Biotech—an Indian drugmaker. Concerns were raised when Uzbek's health ministry said that the syrup contained a toxic substance known as ethylene glycol.&nbsp;

<div class="ui-state-default" contenteditable="false">
<div class="twitter-block" draggable="false">
<blockquote class="twitter-tweet">
Following inspection by <a href="https://twitter.com/CDSCO_INDIA_INF?ref_src=twsrc%5Etfw">@CDSCO_INDIA_INF</a> team in view of reports of contamination in cough syrup Dok1 Max, all manufacturing activities of Marion Biotech at NOIDA unit have been stopped yesterday night, while further investigation is ongoing.
— Dr Mansukh Mandaviya (@mansukhmandviya) <a href="https://twitter.com/mansukhmandviya/status/1608715292091486210?ref_src=twsrc%5Etfw">December 30, 2022</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
<a class="close-mark close-div" href="#" id="jqclosemark">×</a></div>

The Uzbek authorities said that at least 18 children had died in the southeastern city of Samarkand. On Thursday, local media reports claimed that a one-year-old child (19th victim) in the nearby region of Qashqadaryo.&nbsp;

Yesterday, the Indian ministry said that the company's facility has been reviewed. They also mentioned that the samples of the cough syrup have been taken from the manufacturing premises and sent to Regional Drugs Testing Laboratory in Chandigarh for further testing.&nbsp;

While responding to the situation, India's foreign ministry spokesperson Arindam Bagchi said, "We understand that legal action has been initiated by the Uzbek authorities against some people, including the local representative of the company there… And in that context, we are extending necessary consular assistance to those individuals or individual."&nbsp;

WATCH WION LIVE HERE

<iframe allow="accelerometer; autoplay; encrypted-media; gyroscope; picture-in-picture" allowfullscreen="" frameborder="0" height="350" loading="”lazy”" src="https://www.wionews.com/live-tv/embed?autoplay=1&amp;mute=1" width="100%"></iframe>

You can now write for wionews.com and be a part of the community. Share your stories and opinions with us <a href="https://www.wionews.com/content-contribution-registration-form">here</a>.

India on Friday (December 30) suspended cough syrup maker's production after reports emerged that the medicine was linked to the deaths of 19 children in Uzbekistan.

India on Friday (December 30) suspended cough syrup maker's production after reports emerged that the medicine was linked to the deaths of 19 children in Uzbekistan. Indian Health Minister Mansukh Mandaviya said that all production had been suspended at Marion Biotech's unit in Noida, a city in the northern state of Uttar Pradesh. Mandaviya wrote on Twitter on Friday: "All manufacturing activities of Marion Biotech at Noida unit have been stopped yesterday night, while further investigation is ongoing." Hasan Harris, who is the legal head of Marion, told India-based news agency ANI that the company had halted production of all medicines. They are now waiting for the Indian government's report on the inspection. Uzbekistan's health ministry earlier claimed in a statement that the children died after consuming cough syrup Doc-1 Max, manufactured by Marion Biotech—an Indian drugmaker. Concerns were raised when Uzbek's health ministry said that the syrup contained a toxic substance known as ethylene glycol. Following inspection by @CDSCO_INDIA_INF team in view of reports of contamination in cough syrup Dok1 Max, all manufacturing activities of Marion Biotech at NOIDA unit have been stopped yesterday night, while further investigation is ongoing. — Dr Mansukh Mandaviya (@mansukhmandviya) December 30, 2022 × The Uzbek authorities said that at least 18 children had died in the southeastern city of Samarkand. On Thursday, local media reports claimed that a one-year-old child (19th victim) in the nearby region of Qashqadaryo. Yesterday, the Indian ministry said that the company's facility has been reviewed. They also mentioned that the samples of the cough syrup have been taken from the manufacturing premises and sent to Regional Drugs Testing Laboratory in Chandigarh for further testing. While responding to the situation, India's foreign ministry spokesperson Arindam Bagchi said, "We understand that legal action has been initiated by the Uzbek authorities against some people, including the local representative of the company there… And in that context, we are extending necessary consular assistance to those individuals or individual." WATCH WION LIVE HERE You can now write for wionews.com and be a part of the community. Share your stories and opinions with us here.

Uzbekistan cough syrup deaths: India suspends cough syrup maker's production

marion-biotech

Marion Biotech, News on Marion Biotech, stories on Marion Biotech, articles on Marion Biotech, Marion Biotech stories at Wion, Marion Biotech news, Marion Biotech latest news

marion biotech

Marion Biotech's manufacturing licence cancelled over kids' deaths in Uzbekistan

India may issue alert on Marion cough syrup exports as lab tests find toxins

Uzbekistan: Cough syrup kills 19 children, country blames India-made syrups for deaths

Uzbekistan cough syrup deaths: India suspends cough syrup maker's production